Circulating MicroRNA Signature
Quantification of circulating microRNA panels in serum or plasma, investigated for discriminating leprosy from clinical mimics and for predicting type 1 and type 2 reactions.
- Technology
- Host Response · Transcriptomics
- What it measures
- Serum or plasma miRNA panel
- Developer
- Academic groups, including the Instituto Lauro de Souza Lima and the Federal Universities of Minas Gerais and Pará (Brazil)
- Specimen
- Venous blood
- Development status
- Assay in development
- Regulatory status
- None / RUO
- Intended use
- Discrimination from clinical mimics and prediction of type 1 and type 2 reactions
- Main limitation
- Still at the discovery stage, with no validated assay format.
- Linked publications
- 4
- Collaborating institutions
- Southern Medical University (Guangzhou, China), A.C. Camargo Cancer Center (São Paulo, Brazil)
- TPP-1, confirming leprosy
- 20.0 of 100, low alignment
- TPP-2, infection in contacts
- 12.5 of 100, low alignment
Open this test in the landscapeAll 37 tests · Home